NZBio backs fresh debate over new biotechnologies

NZBio has waded into the debate over using new biotechnologies, including genetic modification, backing a call by Treasury secretary Gabriel Makhlouf for another look at New Zealand’s attitude to risk.

Will Barker, chief executive of the biotech industry organisation NZBio, said the Hazardous Substances and New Organisms Act needs to be urgently revised so new organisms are covered by better-conceived legislation.

“Attempts to interpret the current legislation have shown it to be highly restrictive, yet there are considerable benefits that new genetic technologies can offer New Zealanders,” Barker said in a statement today.

Read more